If you'd bought $1000 worth of stock in SIGA Technologies on June 9, 2008, the date I first recommended it, your investment would be worth $1460 today, a 46% gain. By contrast, the S&P 500 has declined since then by 36%.
And the market has not even begun to value SIGA's potential. Its stock price will almost surely pass $10 within the next six to nine months, and that's solely on the power of its leading smallpox drug (contracts with US and EU are imminent), disregarding its mind-bending pipeline, which quietly includes medicines for drug-resistant strep, staph, and pneumonia.
If I had bought it, it probably would have tanked, then you would have blamed me.
ReplyDeleteI have been a SIGA long for two years. If you check out EBS, now $22/sh., you will see the price path SIGA will now follow. EBS got the anthrax deal and went from $5.00 to $24.
ReplyDelete